All the news Showing 10 of 19 articles from: Injecting drug useGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C declining among drug users in UK Keith Alcorn / 11 February 2021 The prevalence of hepatitis C in people who inject drugs has fallen modestly in England, Wales and Northern Ireland and sharply in Scotland since 2016, Public Health England reports. Around one in four ... Hepatitis C vaccine fails to prevent chronic infection Liz Highleyman / 10 October 2019 An experimental two-part vaccine was not able to prevent chronic hepatitis C virus (HCV) infection in a mid-stage study, according to a presentation at the recent IDWeek 2019 conference in Washington, DC. Prof. Andrea ... Recent incarceration increases HIV and hepatitis C risk for people who inject drugs Michael Carter / 19 November 2018 People who inject drugs (PWID) recently released from prison or jail have a substantially increased risk of acquiring infection with HIV or hepatitis C virus (HCV), according to the results of a systematic ... People who inject drugs have a high hepatitis C cure rate despite imperfect adherence Liz Highleyman / 15 November 2018 Most people who inject drugs completed treatment with sofosbuvir/velpatasvir (Epclusa) and achieved sustained virological response (SVR) in a real-world setting, even if they had interruptions in therapy, according to a presentation at the AASLD ... Hepatitis C elimination in people who inject drugs needs a health system strategy, says expert review Keith Alcorn / 24 September 2018 Achieving the elimination of hepatitis C in people who inject drugs will require a comprehensive health system-wide strategy that addresses stigma, barriers to care, financing, the involvement of people who inject drugs and ... HIV and chronic HCV co-infection prevalence in England highest among MSM Michael Carter / 20 August 2018 Men who have sex with men (MSM) make up the majority of people with chronic hepatitis C virus (HCV) who have co-infection with HIV, according to data from Public Health England (PHE) published ... Hepatitis C testing linked to reduced opioid use among people who inject drugs Liz Highleyman / 25 October 2017 Getting tested for hepatitis C virus (HCV) was associated with reduced drug use, especially among those who tested positive, but even people who tested negative saw some reduction, according to study results presented ... Does drug injection equipment other than syringes transmit hepatitis C? Liz Highleyman / 19 September 2017 Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study recently published in The Journal of Infectious Diseases. In an experiment designed ... Hepatitis C virus reinfection is uncommon after being cured with DAAs Liz Highleyman / 22 May 2017 Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during three years of follow-up, researchers reported ... Few young people with HCV in the US live close to needle-exchange services Michael Carter / 11 May 2017 The vast majority (80%) of young people with hepatitis C virus (HCV) infection in the United States have to travel at least ten miles to access needle exchange programmes, investigators report in the ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive